Good news about the Oxford vaccine raises hopes for an exit from the Corona crisis

<div id="firstBodyDiv" data-bind-html-content-type="article" data-bind-html-compile="article.body" data-first-article-body="

British pharmaceutical manufacturer reported "AstraZeneca", That help Manufacture of the vaccineMonday, that’s the vaccine that I developed Oxford university It also results in fewer negative responses among the elderly.

The successful vaccine is seen as a game-changer in the fight against Corona VirusWhich killed more than one million and 115 thousand people, shut down sectors of the global economy and turned normal life upside down for billions of people.

A spokesperson for AstraZeneca said: "It is encouraging to see that immune responses were similar between the elderly and the young, and that the reaction was lower in the elderly, where the severity of the disease is Covid-19 Top".

The spokesman added that "The results further build the body of evidence for vaccine safety and immunity"According to a newspaper reported "The Guardian" British Tuesday.

AstraZeneca did not provide full details of the vaccine, and when the results of the phase III of Clinical trials Vaccine related, which will show whether the vaccine works well enough before it is adopted more broadly.

It is expected to be The first Oxford vaccine One of its kind being developed by major pharmaceutical companies for regulatory approval, along with another vaccine from Bifizer and Biotec.

It considers the news that the elderly are getting Immune response From the vaccine is positive, because the immune system weakens with age, and the elderly are most at risk of dying from the virus.

If successful, the vaccine would allow the world to return to a measure of normality after the pandemic.

“>

British pharmaceutical manufacturer AstraZeneca, which is helping in, reported Manufacture of the vaccineMonday, that’s the vaccine that I developed Oxford university It also results in fewer negative responses among the elderly.

The successful vaccine is seen as a game-changer in the fight against Corona VirusWhich killed more than one million and 115 thousand people, shut down sectors of the global economy and turned normal life upside down for billions of people.

A spokesperson for AstraZeneca said: “It is encouraging to see that immune responses were similar between the elderly and the young, and that the reaction was lower in the elderly, where the severity of the disease is Covid-19 Top”.

The spokesman added that “the results increase the building of a set of evidence for the safety and immunity of the vaccine,” according to the British newspaper “The Guardian”, Tuesday.

AstraZeneca did not provide full details of the vaccine, and when the results of the phase III of Clinical trials Vaccine related, which will show whether the vaccine works well enough before it is adopted more broadly.

It is expected to be The first Oxford vaccine One of its kind being developed by major pharmaceutical companies for regulatory approval, along with another vaccine from Bifizer and Biotec.

It considers the news that the elderly are getting Immune response From the vaccine is positive, because the immune system weakens with age, and the elderly are most at risk of dying from the virus.

If successful, the vaccine would allow the world to return to a measure of normality after the pandemic.

– .